Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Expert Review of Neurotherapeutics|December 20, 2007
Galantamine in Alzheimer's diseaseGeorge Razay, Gordon K WilcockThe Lancet. Neurology|March 17, 2007
Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?Patrick G Kehoe, Gordon K WilcockActa Neuropathologica|September 1, 2005
Loss of perineuronal net N-acetylgalactosamine in Alzheimer's diseaseShabnam Baig, Gordon K Wilcock, Seth LoveInternational Journal of Geriatric Psychiatry|April 4, 2003
Prediction rules for computed tomography in the dementia assessment: do they predict clinical utility of CT?Kelly A Condefer, Judith Haworth, Gordon K WilcockInternational Journal of Geriatric Psychiatry|May 25, 2004
Clinical utility of computed tomography in the assessment of dementia: a memory clinic studyKelly A Condefer, Judith Haworth, Gordon K WilcockJournal of Clinical and Experimental Neuropsychology|August 30, 2013
Computerized adaptation of The Placing Test for early detection of both mild cognitive impairment and Alzheimer's diseaseMarco Vacante, Gordon K Wilcock, Celeste A de JagerInternational Journal of Geriatric Psychiatry|October 9, 2003
The effects of galantamine treatment on caregiver time in Alzheimer's diseaseMary Sano, Gordon K Wilcock, Bart van Baelen, et al.Journal of Alzheimer'S Disease : JAD|June 6, 2014
Is there more to subjective cognitive impairment than meets the eye? A perspectiveAndrea Tales, Gordon K Wilcock, Judith E Phillips, et al.Neurobiology of Aging|August 21, 2003
Absence of Chlamydia pneumoniae in brain of vascular dementia patientsMatthew A Wozniak, Ann Cookson, Gordon K Wilcock, et al.Pageof 7